Navamedic to own a total of 96.33 per cent of shares in Sensidose following closing of public offer

OSLO, Norway, May 26, 2023 /PRNewswire/ — Following the closing of the acceptance period in the previously announced public offer, Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies, will become the owner of 96.33 per cent of the share capital and votes and 93.16 per cent … Read more

Notice of Annual General Meeting

OSLO, Norway, May 11, 2023 /PRNewswire/ — The annual general meeting of Navamedic ASA (OSE: NAVA) will be held on Thursday, June 1st 2023 at 10:00 (CET) in the Navamedic offices in Henrik Ibsens gate 100, 0255 Oslo. The Notice of the Annual General Meeting is attached. The Notice is posted electronically or by mail to … Read more

Navamedic ASA Q1 2023: Another strong quarter

OSLO, Norway, May 11, 2023 /PRNewswire/ — Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies, today announces its results for the first quarter of 2023. Navamedic experienced good momentum across the business and delivered another strong quarter, with record high revenues of NOK 121.7 million, … Read more